On February 26, 2019, top executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee attempting to defend the industry’s business practices. The major focus of…
The Department of Health and Human Services (HHS) appealed the U.S. District Court for the District of Columbia’s decision to enjoin payment cuts for 340B drugs under the 2018 Outpatient…
On Monday, March 11, 2019, HRSA’s Office of Pharmacy Affairs will be hosting a webinar for covered entities that will provide an overview of the secure pricing component of the…
This is a reminder that the 340B annual recertification period for HRSA grantees ends on February 25, 2019. Recertification must be completed through the 340B OPAIS database. The Primary Contact…
In a letter dated February 11, 2019, CVS Caremark announced that it will not implement its plan to reduce payment rates for pharmacies owned by 340B covered entities. These cuts…